Aptevo Therapeutics Shares Move Higher; Co. And Alligator Bioscience Announce Interim Data From Dose Escalation Phase Of Phase 1 ALG.APV-527 Trial Will Be Presented At ESMO Congress 2024 On Sept. 14
Author: Benzinga Newsdesk | September 13, 2024 08:08am